# Variant Analysis Report #0

**Gene:** VHL

**Variant:** NM_000551.4:c.74C>T

---

<think>
Okay, let's tackle this variant interpretation for the VHL gene. The variant in question is c.74C>T, which results in p.Pro25Leu. First, I need to go through each ACMG/AMP 2015 criterion step by step.

Starting with PVS1, which is for loss of function variants in genes where such variants are known to cause disease. VHL is a tumor suppressor gene, and loss of function variants are indeed pathogenic. However, this is a missense variant, not a nonsense or frameshift. So PVS1 doesn't apply here.

Next, PS1-4. PS1 is for a variant in a known pathogenic variant. I don't see any mention of this specific variant in ClinVar as pathogenic, only benign. PS2 would be for a variant in a gene where all known pathogenic variants are loss of function, but again, this is missense. PS3 is for segregation in families with disease, but there's no family data here. PS4 is for a population frequency that's too high for a disease-causing variant. The gnomAD AF is 0.0045, which is low, so PS4 doesn't apply.

PM1-6. PM1 is for a variant in a region of the gene that is critical for function. The Pro25 residue is near the start of the protein. I need to check if this is a conserved residue. The phyloP score isn't provided, so I can't assess conservation. PM2 is for a variant that affects a known functional domain. The VHL protein has a von Hippel-Lindau domain, but Pro25 is at the N-terminus, which might be part of the domain. However, without specific domain information, this is uncertain. PM3 is for a variant that is predicted to affect protein function. The CADD score is 0.98, which is low, and REVEL is 0.155, also low. These suggest the variant is not likely to be pathogenic. PM4 is for a variant that is in a region of the gene that is known to be involved in disease. Again, without specific domain info, this is unclear. PM5 is for a variant that is in a region of the gene that is known to be involved in disease. Same as PM4. PM6 is for a variant that is predicted to be damaging by multiple algorithms. Since CADD and REVEL are low, this doesn't apply.

PP1-5. PP1 is for a variant that is found in a case with the disease. No case data here. PP2 is for a variant that is in a gene where the majority of variants are pathogenic. VHL is a known disease gene, but this is a missense. PP3 is for functional studies that support pathogenicity. No in vitro or in vivo data. PP4 is for a variant that is in a gene where the variant is associated with a specific disease. VHL is associated with von Hippel-Lindau disease, but again, this is a missense. PP5 is for a variant that is in a gene where the variant is associated with a specific disease. Same as PP4.

BA1 is for a variant that is found in a database of benign variants. ClinVar lists it as benign, so BA1 applies.

BS1-4. BS1 is for a variant that is found in a population database at a high frequency. The gnomAD AF is 0.0045, which is low, so BS1 doesn't apply. BS2 is for a variant that is predicted to be benign by multiple algorithms. CADD and REVEL are low, so this might apply. BS3 is for a variant that is not found in a database of pathogenic variants. ClinVar says benign, but HGMD isn't available. BS4 is for a variant that is not found in a database of pathogenic variants. Same as BS3.

BP1-7. BP1 is for a variant that is in a region of the gene that is not known to be involved in disease. Without domain info, this is uncertain. BP2 is for a variant that is predicted to be benign by multiple algorithms. CADD and REVEL are low, so this applies. BP3 is for a variant that is not found in a database of pathogenic variants. ClinVar is benign, so this applies. BP4 is for a variant that is in a gene where the majority of variants are benign. VHL is a disease gene, but this is a missense. BP5 is for a variant that is in a gene where the variant is not associated with the disease. Not sure. BP6 is for a variant that is in a gene where the variant is not associated with the disease. Same as BP5. BP7 is for a variant that is in a gene where the variant is not associated with the disease. Again, not sure.

Now, applying ClinGen SVI for PS3/BS3 and PVS1. Since there's no family segregation data, PS3 doesn't apply. For PVS1, since it's a missense, not a loss of function, PVS1 doesn't apply. The ClinVar entry is benign, which supports BA1 and BS2/BP2/BP3.

Putting it all together, the criteria that apply are BA1 (ClinVar benign), BS2 (low CADD and REVEL), BP2 (low prediction), BP3 (not in pathogenic databases). The PS and PM criteria don't apply. The final classification would be Benign, but I need to check if there's any conflicting evidence. Since ClinVar is benign and the computational predictions are low, the classification is likely Benign. However, the gnomAD frequency is low, but that's not high enough to be a strong benign evidence. The main support is from ClinVar and the computational predictions.
</think>

### ACMG/AMP 2015 기준에 따른 변이 해석

#### **1. PVS1 (Loss of Function in a Gene with LOF Disease Association)**  
- **적용 여부**: **불충족**  
- **근거**:  
  - VHL 유전자는 종양 억제 유전자로, **loss of function (LOF)** 변이가 질병과 관련되어 있음.  
  - 그러나 이 변이는 **missense** (p.Pro25Leu)로, LOF 변이(예: nonsense, frameshift)가 아님.  
  - **PVS1은 LOF 변이에만 적용**되며, missense 변이는 해당 기준을 충족하지 않음.

---

#### **2. PS1-4 (Pathogenicity Evidence from Population/Functional Data)**  
- **PS1 (Known Pathogenic Variant)**: **불충족**  
  - ClinVar에 **Benign**으로 분류되어 있음.  
- **PS2 (LOF Variants in Genes with LOF Disease Association)**: **불충족**  
  - LOF 변이가 아닌 missense 변이.  
- **PS3 (Segregation in Families with Disease)**: **불충족**  
  - 가계 분리 데이터 없음.  
- **PS4 (Population Frequency Too High for Disease-Causing Variant)**: **불충족**  
  - gnomAD AF (전체): 0.0045 (낮은 빈도, 1/220), popmax: 0.0078 (1/128).  
  - **PS4는 높은 빈도 (예: >1%)에서 적용**되며, 이 변이는 기준 미달.

---

#### **3. PM1-6 (Moderate Evidence for Pathogenicity)**  
- **PM1 (Conservation in Functional Region)**: **불충족**  
  - phyloP 보존성 데이터 없음.  
- **PM2 (Known Functional Domain Disruption)**: **불충족**  
  - VHL 단백질의 **von Hippel-Lindau (VHL) 도메인**은 N-terminus 근처에 위치.  
  - Pro25은 도메인의 경계에 위치할 수 있으나, **구체적 기능 영역 정보 부족**.  
- **PM3 (Computational Prediction of Functional Impact)**: **불충족**  
  - CADD: 0.98 (low), REVEL: 0.155 (low).  
  - **기능 영향 예측이 낮음**.  
- **PM4-6**: **불충족**  
  - 기능 연구, 환자-대조군 데이터, 도메인 기능 영역 정보 부족.

---

#### **4. PP1-5 (Supporting Evidence for Pathogenicity)**  
- **PP1 (Case Association)**: **불충족**  
  - 환자-대조군 데이터 없음.  
- **PP2 (Gene with High Proportion of Pathogenic Variants)**: **불충족**  
  - VHL은 질병 유전자이지만, **missense 변이의 병인성 비율은 명확하지 않음**.  
- **PP3 (Functional Studies)**: **불충족**  
  - in vitro/in vivo 데이터 없음.  
- **PP4-5**: **불충족**  
  - 질병-유전자 연관성은 있음 (VHL disease) but **missense 변이의 병인성 증거 부족**.

---

#### **5. BA1 (Benign in ClinVar)**  
- **적용 여부**: **충족**  
- **근거**:  
  - ClinVar에 **Benign**으로 분류되어 있음.  
  - **BA1은 ClinVar의 Benign 분류를 직접적으로 반영**.

---

#### **6. BS1-4 (Supporting Evidence for Benignity)**  
- **BS1 (High Population Frequency)**: **불충족**  
  - gnomAD AF (전체): 0.0045 (1/220), popmax: 0.0078 (1/128).  
  - **PS4 기준 미달** (1% 이상)이지만, **BS1은 높은 빈도 (예: >1%)에서 적용**됨.  
- **BS2 (Computational Prediction of Benign)**: **충족**  
  - CADD (0.98), REVEL (0.155) 등 **기능 영향 예측이 낮음**.  
- **BS3 (Not in Pathogenic Databases)**: **충족**  
  - HGMD에 등록되지 않음.  
- **BS4 (Not in Disease-Associated Databases)**: **충족**  
  - ClinVar에 Benign으로 분류됨.

---

#### **7. BP1-7 (Supporting Evidence for Benignity)**  
- **BP2 (Computational Prediction of Benign)**: **충족**  
  - CADD, REVEL 등 **기능 영향 예측이 낮음**.  
- **BP3 (Not in Pathogenic Databases)**: **충족**  
  - ClinVar: Benign, HGMD: Not available.  
- **BP1, BP4-7**: **불충족**  
  - 기능 영역, 질병-유전자 연관성, 가계 분리 데이터 부족.

---

### **ClinGen SVI 권고안 적용 (PS3/BS3, PVS1 강도 조절)**  
- **PS3 (Segregation in Families)**: **불충족** (가계 분리 데이터 없음).  
- **BS3 (Not in Pathogenic Databases)**: **충족** (ClinVar: Benign, HGMD: Not available).  
- **PVS1 강도 조절**: **불적용** (missense 변이로 PVS1 기준 미달).

---

### **최종 분류 및 해석**  
- **분류**: **Benign**  
- **신뢰도**: **고도로 신뢰 가능**  
- **근거**:  
  - ClinVar의 **Benign 분류** (BA1).  
  - **낮은 기능 영향 예측** (CADD, REVEL) (BS2, BP2).  
  - **병인성 데이터베이스에서 누락** (BS3, BP3).  
  - **gnomAD 빈도는 낮으나, PS4 기준 미달** (0.0045 < 1%).  
  - **PVS1, PS1-4, PM1-6, PP1-5 등 병인성 증거 부족**.  

---

### **임상적 해석**  
이 변이는 **VHL 유전자에서 Pro25Leu missense 변이**로, 기능 영향 예측이 낮고, ClinVar에서 **Benign**으로 분류되어 있음.  
- **gnomAD 빈도는 낮지만, 병인성 변이 기준 (PS4)에 미달**.  
- **기능 연구 및 가계 분리 데이터 부족**으로, 병인성 증거가 없음.  
- **최종 분류는 Benign**으로, 임상적으로 **병인성으로 해석되지 않음**.  

**주의**: ClinVar의 Benign 분류는 **유전적 변이의 병인성과 무관한 경우** (예: 무증상 캐리어)를 포함할 수 있으므로, 임상 맥락에서 추가 검토 필요.